公开(公告)号：EP0927252B1

公开(公告)日：2006-10-18

申请号：EP97919622.7

申请日：1997-04-29

Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.

Inventor： NOVICK, Daniela ,  RUBINSTEIN, Menachem

IPC: C12N15/13 ,  C07K16/28 ,  A61K39/395 ,  C12N5/20 ,  G01N33/577 ,  G01N33/53

CPC classification number: C07K16/2866 ,  A61K38/00 ,  C07K2317/76

Abstract: Antibodies directed against the ligand binding component of the interferon- alpha / beta receptor are provided, which are capable of selectively modulating the activity of various type-I interferons.

公开(公告)号：EP0927252A1

公开(公告)日：1999-07-07

申请号：EP97919622.0

申请日：1997-04-29

Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.

Inventor： NOVICK, Daniela ,  RUBINSTEIN, Menachem

IPC: C12N15 ,  A61P37 ,  A61P43 ,  C07K16 ,  C12N5 ,  C12P21 ,  G01N33 ,  A61K38

CPC classification number: C07K16/2866 ,  A61K38/00 ,  C07K2317/76

Abstract: Antibodies directed against the ligand binding component of the interferon-α/β receptor are provided, which are capable of selectively modulating the activity of various type-I interferons.